ICCC (STOCKS)
Immucell Corp
$6.490000
-0.140000 (-2.11%)
Prev close: $6.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Olivier te Boekhorst
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $62.38M
- Employees
- 76
- P/E (TTM)
- 25.61
- P/B (TTM)
- 2.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.02 | $0.00 | +0.0000 | +0.00% |
|
Jun 2025 (Q2)
|
$0.06 | $0.00 | +0.0000 | +0.00% |
|
Mar 2025 (Q1)
|
$0.16 | $0.00 | +0.0000 | +0.00% |
|
Dec 2024 (Q4)
|
$0.06 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $27.77M |
| Benefits Costs and Expenses | -$3.21M |
| Cost Of Revenue | $16.40M |
| Costs And Expenses | $24.92M |
| Gross Profit | $11.37M |
| Nonoperating Income/Loss | $9.31K |
| Operating Expenses | $9.04M |
| Research and Development | $3.10M |
| Other Operating Expenses | $5.94M |
| Operating Income/Loss | $2.33M |
| Income/Loss From Continuing Operations After Tax | $30.97M |
| Income/Loss From Continuing Operations Before Tax | $2.34M |
| Income Tax Expense/Benefit | $14.30K |
| Net Income/Loss | $2.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $2.32M |
| Net Income/Loss Available To Common Stockholders, Basic | $2.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.28 |
| Diluted Earnings Per Share | $0.28 |
| Basic Average Shares | 9,278,303 |
| Diluted Average Shares | 9,278,303 |
| Assets | $45.73M |
| Current Assets | $16.83M |
| Inventory | $9.80M |
| Prepaid Expenses | $527.87K |
| Other Current Assets | $6.50M |
| Noncurrent Assets | $28.90M |
| Fixed Assets | $24.34M |
| Other Non-current Assets | $4.56M |
| Liabilities | $15.93M |
| Current Liabilities | $4.00M |
| Noncurrent Liabilities | $11.93M |
| Long-term Debt | $9.49M |
| Other Non-current Liabilities | $2.44M |
| Equity | $29.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $29.80M |
| Liabilities And Equity | $45.73M |
| Net Cash Flow From Operating Activities | $1.99M |
| Net Cash Flow From Operating Activities, Continuing | $1.99M |
| Net Cash Flow From Investing Activities | -$1.24M |
| Net Cash Flow From Investing Activities, Continuing | -$1.24M |
| Net Cash Flow From Financing Activities | -$668.92K |
| Net Cash Flow From Financing Activities, Continuing | -$668.92K |
| Net Cash Flow | $77.57K |
| Net Cash Flow, Continuing | $77.57K |
| Comprehensive Income/Loss | $2.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $2.32M |
| Other Comprehensive Income/Loss | $0.00 |